Gabelli & Co Investment Advisers’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-42,399	Closed	-$4.25M	–	207
2015 Q1	$4.25M	Buy	+42,399	New	+$2.82M	0.71%	30

Gabelli & Co Investment Advisers's ASPX Position: Q2 2015 in Review

Gabelli & Co Investment Advisers sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 42,399 shares — an estimated $4.25M sold.

Gabelli & Co Investment Advisers first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $4.25M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Gabelli & Co Investment Advisers reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 42,399 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $4.25M.
Gabelli & Co Investment Advisers first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Gabelli & Co Investment Advisers's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4.25M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2015, filed 5 Aug 2015.